Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07221604 · ClinicalTrials.gov registry record · NA
The Agenda-Setting for Kidney Disease Open Pilot Trial
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07221604 is a NA study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT07221604, a NA study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this open pilot is to practice using an intervention and surveys before a larger pilot stepped wedge clinical trial. The intervention the researchers plan to use is Chronic Kidney Disease (CKD) Topics, and it is a structured clinical agenda-setting intervention (SAS), or a customized list of discussion topics. The people the researchers are practicing using the SAS with have advanced CKD (stages 4-5), and many of them live in rural areas. The researchers will practice administering CKD Topics, along with survey questions. By doing the open pilot, the researchers will learn if they need to modify the steps they plan to take in the larger trial. The main questions the researchers aim to answer are: * Do the steps for identifying eligible participants work? * Do the steps for administering CKD Topics work? * Do the steps to administer survey questions work?
Interventions
- BEHAVIORAL Chronic Kidney Disease Structured Agenda-Setting Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07221604
The ClinicalTrials.gov registry entry for NCT07221604 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chronic Kidney Disease Structured Agenda-Setting Tool is the first listed.
NCT07221604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07221604 about?
NCT07221604 is a clinical study titled "The Agenda-Setting for Kidney Disease Open Pilot Trial". The goal of this open pilot is to practice using an intervention and surveys before a larger pilot stepped wedge clinical trial. The intervention the researchers plan to use is Chronic Kidney Disease (CKD) Topics, and it is a structured clinical agenda-setting intervention (SAS), or a customized lis...
What is the current status of trial NCT07221604?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-07. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07221604?
The interventions under investigation include: Chronic Kidney Disease Structured Agenda-Setting Tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT07221604?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.